Hyperhomocysteinemia is an independent risk factor for cardiovascular disease.1) Elevation of homocysteine (HCY) in blood plasma (Ͼ15 mmol/l), resulting from metabolic abnormalities in HCY remethylation or transsulfuration, is common in subjects with cardiovascular disease. In the last decade, insights from the animal models have established that experimental hyperhomocysteinemia produces several phenotypic effects, including endothelial dysfunction. The most common abnormality of the dysfunction observed during hyperhomocysteinemia is impaired relaxation of conduit vessels (aorta, carotid arteries, renal, or pulmonary) or impaired dilatation of micro vessels (mesenteric, cremasteric, coronary, skeletal, or cerebral arterioles) in response to the endothelium-dependent vasodilators in rat, mice, monkey, or guinea pigs, whereas no impairment was seen in response to exogenous nitric oxide (NO) donors.2-8) Therefore, it was suggested that the underlying mechanism by which endothelium derived NO, which then diffuses into the adjacent vascular muscle layer and causes its relaxation, may play an important role in mediating these deleterious effects on endothelial function in hyperhomocysteinemia. 2,5,8) Furthermore, the emerging evidence suggest that hyperhomocysteinemia leads to increased vascular superoxide production through the upregulation and activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and that reactive oxygen species (ROS) generated by NADPH oxidase contribute to the vascular phenotype. 4,[9][10][11] Radix Astragali is the dried root of Astragalus membranaceus (FISCH.) BGE. var. mongholicus (BGE.) HSIAO or Astragalus membranaceus (FISCH.) BGE. It has been widely used in Chinese medicine since ancient times for the improvement of immune disorders and management of cardiovascular diseases with an excellent safety.12) Research suggests that this herb was able to inhibit free radicals, decreases lipid peroxidation, and increases antioxidant enzymes.13) Many medicinally active compounds have been isolated from this plant, including polysaccharides, flavones and astragalosides. Astragalosides is the major active component extracted from the root of Astragalus membranaceus.12) Previous studies from our laboratory demonstrated that crude astragalosides fraction can potently protect endothelium-dependent relaxation against the acute injury from HCY through nitric oxide regulatory pathways, in which antioxidation played a key role.
14)Astragaloside IV (AST-IV), 3-o-beta-D-xylopyranosyl-6-obeta-D-glucopyranosyl-cycloastragenol (Fig. 1), was a small molecular saponin. AST-IV can exert multipotent activities under pathophysiological conditions, such as anti-hypertension, 15) positive inotropic action, 16) anti-inflammation, 17) and anti-infarction.18) Up to now, however, whether AST-IV has an exact protective effect on vessels in hyperhomocysteinemia and the mechanism are not known. The aim of the present study is to examine the effect of AST-IV on vasomotor dysfunction induced by HCY in rat ao...